Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins Block Distinct Steps in Transendothelial Migration of Effector Memory CD4+T Cells by Targeting Different Endothelial Proteins

被引:32
作者
Manes, Thomas D. [1 ]
Hoer, Simon [2 ,3 ]
Muller, William A. [4 ]
Lehner, Paul J. [2 ,3 ]
Pober, Jordan S. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA
[2] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England
[3] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2QQ, England
[4] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA
基金
美国国家卫生研究院; 英国惠康基金;
关键词
CD4(+) T-CELLS; ADHESION MOLECULE-1 CD31; DOWN-REGULATION; CLASS-I; SURFACE GLYCOSAMINOGLYCANS; ANTIGEN PRESENTATION; COUNTER-RECEPTOR; PECAM-1; EXPRESSION; ICAM-1;
D O I
10.4049/jimmunol.0902938
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
ORFK3 (K3) and ORFK5 (K5) are Kaposi's sarcoma-associated herpesvirus-encoded E3 ubiquitin ligases that differentially reduce surface expression of various proteins in infected cells. In this study, we describe their effects on human dermal microvascular endothelial cells (ECs), a natural target of Kaposi's sarcoma-associated herpesvirus infection. TNF-treated human dermal microvascular ECs transduced to express K5 show reduced capacity to capture effector memory (EM) CD4+ T cells under conditions of venular shear stress. K5 but not K3 transduction significantly reduces ICAM-1 expression and the inhibition of T cell capture was phenocopied by small interfering RNA knockdown of ICAM-1 and by anti ICAM-1 Ab blocking. Cotransduction with an ICAM-1 truncated construct not subject to K5 ubiquitylation restored EM CD4+ T cell capture. K3 transductants effectively capture EM CD4+ T cells, but fail to support their transendothelial migration (TEM) in response to TCR engagement by superantigen presented by the ECs, leaving intact chemokine-dependent TEM. K3 but not K5 transduction significantly reduces PECAM-1 expression, and the effect on TCR-induced TEM is phenocopied by small interfering RNA knockdown of PECAM-1 and by anti PECAM-1 Ab blocking. TCR-dependent TEM was restored in K3 transductants cotransduced to express a mutant of PECAM-1 not subject to K3-induced ubiquitylation. EM CD4+ T cells lack any known PECAM-1 counter receptor, but heterophilic engagement of PECAM-1 can involve glycosaminoglycans. In addition, TCR-induced TEM, but not chemokine-induced TEM, appears to involve a heparan- or chondroitin-like molecule on T cells. These results both identify specific roles of K5 and K3 in immune evasion and further differentiate the processes of inflammatory chemokine- versus TCR-dependent recruitment of human EM CD4+ T cells. The Journal of Immunology, 2010, 184: 5186-5192.
引用
收藏
页码:5186 / 5192
页数:7
相关论文
共 29 条
[1]   Quantitative membrane proteomics reveals new cellular targets of viral immune modulators [J].
Bartee, Eric ;
McCormack, Ashley ;
Fruh, Klaus .
PLOS PATHOGENS, 2006, 2 (10) :975-988
[2]  
BIRD IN, 1993, IMMUNOLOGY, V80, P553
[3]   Increased ICAM-1 expression causes endothelial cell leakiness, cytoskeletal reorganization and junctional alterations [J].
Clark, Paul R. ;
Manes, Thomas D. ;
Pober, Jordan S. ;
Kluger, Martin S. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (04) :762-774
[4]   Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis [J].
Coscoy, L ;
Ganem, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) :8051-8056
[5]   A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation [J].
Coscoy, L ;
Ganem, D .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (12) :1599-1606
[6]   Immune evasion by Kaposi's sarcoma-associated herpesvirus [J].
Coscoy, Laurent .
NATURE REVIEWS IMMUNOLOGY, 2007, 7 (05) :391-401
[7]  
Deaglio S, 1998, J IMMUNOL, V160, P395
[8]  
DELISSER HM, 1993, J BIOL CHEM, V268, P16037
[9]   Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus [J].
Hong Y.-K. ;
Foreman K. ;
Shin J.W. ;
Hirakawa S. ;
Curry C.L. ;
Sage D.R. ;
Libermann T. ;
Dezube B.J. ;
Fingeroth J.D. ;
Detmar M. .
Nature Genetics, 2004, 36 (7) :683-685
[10]   Inhibition of natural killer cell-mediated cytotoxicity by kaposi's sarcoma-associated herpesvirus K5 protein [J].
Ishido, S ;
Choi, JK ;
Lee, BS ;
Wang, CY ;
DeMaria, M ;
Johnson, RP ;
Cohen, GB ;
Jung, JU .
IMMUNITY, 2000, 13 (03) :365-374